Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
The story of Polyethylene Glycol 1500 stretches back well into the 20th century, a time when the pharmaceutical industry searched for stable, safe carriers and bases for drugs. Chemists realized early that polymers like PEG could do more than just thicken a solution; they could transform the delivery and reliability of medicines. By the middle of the century, major pharmacopoeias like BP, EP, and USP started adopting clear definitions for PEG grades, including the 1500 variant. Companies and labs stuck with PEG because it handled storage, transport, and scale-up with fewer headaches than natural alternatives. From old-time ointments to the tailored polymers found in tablets today, PEG 1500’s historical roots grew from necessity and an eagerness to shield sensitive drugs from environmental instability.
Pharma grade PEG 1500 comes as colorless or nearly white waxy pellets—easy enough to handle at room temperature. Rubbing a handful of these solid beads, you feel them start to soften around your body heat. This point sits close to PEG 1500’s melting range, 44–48°C. Unlike lower weight PEGs, which flow like syrup, PEG 1500 balances firmness for molding and enough flex to blend into mixes. Its pharmaceutical status requires strict monitoring of impurities, heavy metals, and water content. Reputable sources run this material up against international standards, checking every drum for impurities like ethylene oxide or dioxane down to tiny traces. Pharma runs on predictability, so manufacturers tie technical specs to BP, EP, and USP guidelines, assigning batch numbers and keeping records for years. Labels list more than just weight or polymer code—they show compliance, lot traceability, expiration, and precise storage needs.
Every batch of PEG 1500 feels consistent, with molecular chains falling within tight lengths—this is no loose family reunion, but a well-organized line dance. Its solubility in water and many solvents allows quick mixing. Hydrophilicity stands out, pulling in and combining with water-based drugs and active compounds. PEG 1500 resists many forms of chemical attack, whether the threat comes from oxygen, acids, or more temperamental excipients. Few bacteria or fungi possess the stomach to digest PEG, so issues like spoilage or unexpected chemical breakdown take a back seat. The melt characteristics of PEG 1500 mean it locks ingredients firmly in place and rarely seeps or leaches, so ointments stay where pharmacists want them. These traits grow from its molecular backbone—long, repeating segments of ethylene oxide hooked together, end-capped with a couple of hydroxyl groups.
Pharmaceutical regulations leave little room for guesswork. Every container needs specific data: batch ID for traceability, purity rated above 98%, moisture below a certain threshold, detailed storage and handling practices, and regulatory compliance marks for the relevant pharmacopoeias. This dedication to transparency trickles down to daily operations in manufacturing and compounding pharmacies—everyone from QC analysts to pharmacists needs confidence in each critical characteristic. Technical sheets set benchmarks like bulk density, acid values, and foreign matter detection, so any deviation triggers a hard stop in the workflow. Proper labeling doesn’t just help investigators, but reassures every nurse and chemist that the drug vehicle in play matches what regulators and patients demand.
Building PEG 1500 starts in stainless steel reactors where ethylene oxide gets coaxed into a long chain with controlled catalysts. The challenge speaks to every chemical engineer’s careful hand—control the heat, limit water, stop side reactions. After polymerization, extra steps wash, distill, or filter away unreacted elements, byproducts, and residual catalysts. This degree of attention means no shortcuts or skimping on equipment that can monitor purity or shut down a process when numbers skew off course. Every lot must mirror the ones before, ready for the repeat scrutiny of audits and inspections. Consistent process control separates pharma grade from industrial PEG; the customer base includes hospitals, children, and immunocompromised folks, not just manufacturers of adhesives or paints. Anyone who has walked a plant floor understands the patience needed—endless checks, redundant filters, hours spent fine-tuning for that perfect melt point or chain length.
PEG 1500 presents as a reliable participant in chemical reactions, seldom causing drama for manufacturers. Its terminal hydroxyl groups open the door for modifications like esterification or etherification. Drug companies often tether drugs or targeting ligands to PEG chains to extend the half-life of delicate actives in the body. For thousands of formulations, this chemical stability ensures no unpleasant surprises—no color shifts, no funky odors, and no hazardous byproducts. When researchers want to fine-tune a product, they can choose the right molecular weight or even cross-link PEG 1500 into network structures for drug delivery or wound dressings. The chemical community values PEG 1500 for its predictability in reactions, and the knowledge that reliable transformation paths remain open, with few barriers to custom uses down the line.
Walk into a chemical catalog and PEG 1500 appears under several banners: polyethylene glycol 1500, macrogol 1500, Carbowax 1500, Pluriol E 1500. Depending on the supplier or reference, slight naming shifts emerge, but the structure holds fast. In hospital supply closets, pharmacy textbooks, or pharmaceutical registrations, the primary code—PEG 1500—carries authority. Regulatory frameworks often point to unique identification numbers, such as CAS: 25322-68-3, to eliminate confusion. Synonyms serve as historical fingerprints, tracing back to the early inventors who each branded their own version, but science and commerce eventually circled back to a common understanding.
Safety standards for PEG 1500 read as a clear response to decades of observation and rigorous case reviews. PEG 1500 offers a high margin of safety in pharmaceutical use, with allergies or severe reactions barely making it into the literature. Labs and production sites don’t cut corners—materials stay sealed, operators use gloves, and quick communication keeps spills contained. Ingestion risks, environmental concerns, or contact hazards rarely rise above routine. Training materials focus on labeling, transport safety, batch recall strategy, and regular staff refreshers. In pharma plants and compounding labs, these standards become common sense, as any sign of mislabeling, contamination, or incomplete documentation threatens trust. Regulatory controls set by BP, EP, and USP create a linked chain between industry, retail pharmacists, and end-users, so accountability never slips.
PEG 1500 steps up in tablet coatings, solid dispersions, ointments, and some injectable formulations. Pharmacies and hospitals like its ability to bind powders, hold moisture, and melt smoothly at manageable temperatures. Its role in suppositories underlines the importance of a base that melts predictably without irritating sensitive tissues. Sometimes it blends with higher or lower molecular weight PEGs for specific needs: softer ointments use more PEG 400, firmer bases count on 1500’s bulk. Animals benefit, too—veterinary formulations leverage PEG’s gentle profile for wide tolerability. PEG 1500 doesn’t just stick around for its safety, but for the way it improves the lifespan and usability of products already proven effective.
Research never sits still, and PEG 1500 now features in drug delivery systems where old carriers once failed. Recent years brought attention to its use in nanomedicine, such as nanoparticle surface coatings, prolonging circulation time and outsmarting the immune system long enough for drugs to do their job. Scientists have dug deeper into improving PEG clearance from the body, tweaking structures to minimize unwanted build-up in organs or potential interaction with immune cells. Teams continue testing PEG conjugations as stealth layers on biologics, trying to sharpen targeted therapies for cancer or autoimmune diseases. The focus extends to bio-degradability and ecological impacts, given the rising drumbeat about microplastics and environmental persistence. Plenty of research funding heads toward more sustainable, functional PEG derivatives inspired by PEG 1500’s legacy in pharma.
Decades of studies circle back to one message: PEG 1500 behaves as a low-toxicity, low-sensitization option at typical pharmaceutical concentrations. The rare allergic reaction gets flagged and tracked, but the majority of side effects tie back to overuse, high ingestion, or specific hypersensitive individuals. Toxicity trials in rats, rabbits, and cultured human cells consistently show tolerance even at doses much higher than therapeutic ranges. PEG’s journey through the body, excretion mainly unchanged, brings confidence to long-term use in both adults and children. Reports occasionally question very specific subpopulations, such as those with known PEG allergies or some immunological responses—these findings drive stricter excipient screening in new drug trials. Physicians and pharmacists lean hard on the record of safety, using that knowledge to support choices in delicate patient cases.
Development rarely lets even established substances coast for long. PEG 1500’s next chapters include tweaks to improve traceability, add environmental features, and sidestep any leftover synthetic byproducts. Growing scrutiny over micro-plastic formation pushes new research into bio-sourced alternatives or PEGs that break down under controlled conditions. The pharma world expects excipients to do more: blend with new drug forms, punch above their molecular weight, and interact seamlessly with digital quality control systems. In the hands of expert formulators, PEG 1500 will keep shining in solid and semisolid drugs, especially as more therapies shift toward precise, patient-tailored regimens. The lesson for anyone in pharma or chemistry: pay attention to every polymer’s quirks, ask tough questions about sourcing and sustainability, and push product evolution with every new piece of evidence uncovered.
Polyethylene Glycol 1500, often shortened to PEG 1500, lives in many tablets and capsules you see at the pharmacy. Some folks don’t notice its name in the ingredients list, overwhelmed by all the tricky words that come with modern medicine. It’s not the ingredient that fights bacteria or lowers blood pressure. Instead, it brings those powerful ingredients together and helps carry them safely into the body.
Manufacturers lean on PEG 1500 for plenty of reasons. In my work, I’ve seen its flexibility first-hand. It acts as a binder, which means it keeps powders pressed together in tablets from falling apart in the bottle. It has enough stickiness to form smooth, solid tablets, but it doesn't gum up the production line. This property matters in mass production, where every tablet needs the same target weight and firmness for quality control.
PEG 1500 holds a steady melting point, which gives it an edge in making suppositories. It melts at body temperature, releasing medicine right where it’s needed without leaving behind strange textures or grit. This experience alone has made it a cornerstone of both pediatric and geriatric medicine, where delicate delivery counts.
Not all drugs come as pills or capsules. Some need to coat a tablet’s surface to taste less bitter or dissolve more slowly. PEG 1500 helps with this job, too. It forms a smooth shell and can mix with active ingredients so the body absorbs medicine gradually. As a coating agent, it doesn’t just mask taste. It helps medicines travel past the acidic stomach unchanged, working where doctors want them most.
With its mild nature, PEG 1500 makes a favorite in topical creams. It carries medication into the skin without triggering allergies or turning greasy. For folks who struggle with oily sensations or skin reactions, PEG 1500 offers a lotion that feels both safe and light. In ointments, its solubility helps dissolve other substances, making even stubborn medicines less likely to separate out when stored.
Pharmaceutical work lives or dies by consistency. Every patient expects their prescription to be just right, every single time. PEG 1500 keeps active drugs evenly distributed, so no part of a tablet gives an unpredictable dose. Because PEG is stable even after months on a shelf, pharmacists can trust what they give out today will perform the same way much later.
PEG 1500’s reputation depends on strict standards set by authorities like the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP). Meeting these measures means the compound avoids common impurities, keeping unwanted reactions low. In my experience, such vigilance from oversight groups eases doctors’ and patients’ worries about long-term safety.
No ingredient stands alone. Even one as reliable as PEG 1500 pushes firms to look for cleaner manufacturing routes or more sustainable packaging. The industry debates sourcing and environmental impact as green chemistry becomes more urgent.
PEG 1500 earned its spot through reliability and technical strength. Each tablet and ointment might look simple, but they rely on ingredients like this to deliver treatment everyone can trust.
Polyethylene Glycol 1500, often shortened as PEG 1500, shows up in everything from laxatives to certain candies and capsules. It acts as a base in pills, a binder in tablets, and even as a solvent or plasticizer. From my own experience, that waxy coating on some pills and those soft chewy textures in medicines can be linked to substances like this.
The U.S. Food and Drug Administration (FDA) has listed several versions of polyethylene glycol as “generally recognized as safe” (GRAS) in food. Drug regulators in Europe and elsewhere have approved PEG as an excipient and as an active ingredient in osmotic laxatives. Scientists have studied it for decades, since the 1940s, and its safety record holds strong when used in recommended amounts.
Researchers know exactly how the body reacts to PEG 1500. The molecule passes through the digestive system mostly unchanged, so it does not build up in the body. In pills, it helps hold everything together and controls how the drug dissolves. Many people don’t even notice its presence, because the body flushes it out in the urine. I’ve read that rare allergies to polyethylene glycols happen, but they’re really unusual—most people do fine even with regular use.
Safety doesn’t mean risk-free, and that’s worth keeping in mind. Some folks do react to PEGs, especially at high doses. Around 2018, hospitals in New Zealand saw allergic reactions linked to some bowel prep products. Other reports tied it to anaphylactic reactions from injected medicines. These allergic responses usually affect people who already have sensitivities or who received a high dose. For most of the population, this ingredient causes little trouble.
Experts have tested it for harm in animals and followed people after years of using prescription products with PEGs. PEGs themselves are not carcinogenic, and studies in rats using huge doses for months still could not find proof of tumors or organ damage. That's a relief, given how common PEGs have become.
Food and pharmaceutical companies work with strict rules for what goes into products. The FDA and international agencies require heavy documentation, routine purity checks, and traceability of raw ingredients. If you’re using a medicine or eating a snack with PEG 1500, its manufacturing line likely passed audits and safety checks. These controls keep contamination low and lower the risk of impurities, like ethylene oxide or dioxane, which naturally raise concern if left unchecked. Regular monitoring tackles most of these concerns directly at the plant.
Better education can help both consumers and doctors spot trouble faster. Transparent labeling matters as food allergies climb and patients try multiple medicines. Companies can push for purer PEGs by updating chemical purification standards. Medical teams should listen to anyone with an unusual reaction and report it, because it helps regulators spot problems earlier.
It pays to talk with a health professional, especially for anyone sensitive to additives or living with allergies. Doctors and pharmacists can guide safer swaps if a reaction pops up. Ongoing studies, open reporting lines, and label transparency build trust. PEG 1500 does its job for most people, showing that through science and vigilance, we really can balance progress and safety.
Polyethylene Glycol 1500—often called PEG 1500—plays a trusted role in pharmaceuticals, cosmetics, and other sensitive industries. Talk to any formulator and you'll hear the same thing: quality standards mean everything for safety, consistency, and legal compliance. Most of us who’ve spent time on the manufacturing or R&D side expect to see clear references to international pharmacopoeias like BP, EP, and USP. These acronyms represent the British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia. Each one lays down its own requirements for those using PEG 1500 in critical applications.
PEG 1500 sits in a middle range of polyethylene glycols when it comes to average molecular weight—roughly 1300 to 1600 g/mol. It appears as a white, waxy solid at room temperature and melts between 44°C and 48°C. The reason for this specific range is practical; a consistent melting point gives manufacturers predictable behavior under typical storage and handling conditions. The product feels slightly oily to the touch, dissolves easily in water, and blends with many organic solvents.
A good batch will carry almost no odor and leave no unusual taste, which is critical for anything aimed at oral or topical use. PEG 1500’s low toxicity gives it the pharmaceutical industry’s nod, often showing up as a base for ointments, capsules, and even laxatives.
Every lot must meet tight chemical identity tests—BP, EP, and USP all demand a clear match through infrared absorption or other chemical markers. Water content has to stay low, usually below 2%. Too much moisture can encourage product breakdown or affect drug consistency. The hydroxyl value—measuring the number of reactive hydroxyl groups—helps confirm the claimed molecular weight.
Acidity and alkalinity parameters aim to keep pH friendly and predictable, which guards against unwanted side reactions. Peroxide levels get special attention, as high peroxides can signal product degradation and trigger concerns about long-term stability. Residues such as heavy metals stay strictly limited (often below 10 ppm for lead), since their presence could harm patients and wreck a product’s marketability.
I’ve watched teams caught off guard by off-spec PEG in production. If a batch slips through with poor water control or out-of-range pH, the finished product can show unexpected particle formation, change texture, or even lose active ingredient stability. No one wants those calls from regulatory bodies. Laboratories run a routine list: basic appearance, melting point, water content (often by Karl Fischer titration), and checks for impurities like ethylene oxide and diethylene glycol—both costly risks for patient safety and company reputation.
Some manufacturers face supply chain issues with PEG 1500 quality. It’s tempting to cut corners, especially on price, but shortcuts almost always bring bigger headaches later. To avoid this trap, the best teams insist on COAs (certificates of analysis) for every batch, audit suppliers regularly, and hold vendor relationships to high standards. Some go as far as running their own independent QC alongside supplier documents.
Automation in quality control now gives faster, more accurate readings. Digital records can flag trends or subtle shifts in quality before they become major recalls. What’s made the biggest difference is building a real culture of transparency—open reporting of failures leads to rapid fixes and safer products, instead of costly surprises down the line.
Anyone responsible for delivering safe products knows PEG 1500 isn’t just a commodity—it’s an ingredient that can make or break batch consistency and consumer trust. Standards like BP, EP, and USP keep everyone honest, but it's people, processes, and an obsession with quality that set the winners apart.
Polyethylene Glycol 1500, often used in pharmaceutical and cosmetic fields, looks a lot like waxy white flakes or pellets at room temperature. This seemingly simple material has a strong record for helping as a base for creams, ointments, and other products. The way shops and labs store and handle this compound makes a big difference in the finished product’s quality and the safety of everyone working with it.
Storing PEG 1500 in a hot and humid storeroom usually ends with clumped pellets and changes in texture. As someone who has worked around both bustling pharmacies and tight laboratory environments, I’ve seen that good practices come from attention to simple details. Moisture, sunlight, and high heat rank as the biggest threats. These factors can make the compound degrade or grow sticky, which causes trouble later during production and when measuring doses accurately. A dry, cool, and shaded spot often works best. The temperature should ideally stay below 25°C (77°F). Anyone who’s stored their baking chocolate near the kitchen window knows unexpected warmth can ruin even stable solids.
Accurate labeling is more than a compliance box to tick–it reduces accidents and guesswork. Every container should have the exact chemical name, batch number, and expiration date easy to see. Staff members who know exactly what’s in a drum or jar won’t mix up PEG 1500 with other similar-looking powders or flakes used in-house, such as PEG 4000 or stearic acid. Keeping these supplies in separate, clearly labeled zones limits mistakes.
Handling this compound has risks that show up in odd ways. Even small spills can become slip hazards or lead to cross-contamination. Wearing gloves and proper protective gear keeps skin safe and prevents oily fingerprints on batches, which might alter the next formulation. I’ve lost count of the cleanup headaches caused by casual handling. Scoops, utensils, and working surfaces must stay clean and dry–water and dirt often lead to more than just simple messes. Avoid using old or wooden scoops, as they hold onto moisture.
PEG 1500 is not known for strong odors or dangerous fumes, but good airflow remains important. In hot or poorly ventilated storage rooms, fine dust can accumulate and end up in the air. While it’s unlikely to pose grave health threats, dust can create a mess that’s annoying and hard to remove from sensitive devices. Ensuring decent air circulation and regular dusting absorbs much of the potential risk.
Accidents happen anywhere, even with the most organized storage system. Spill kits and up-to-date safety information should stay close by. Simple instructions go a long way–everyone on the floor deserves to know how to respond if a bag rips or granules scatter. From experience, it’s far easier to manage the aftermath of an accident with good preparation rather than panic. Regular safety drills keep skills sharp and create a safer workplace.
Responsible handling and clear protocols build trust, not just among team members, but also down the line to customers and public health authorities. Pharmaceutical companies and researchers who stick to best practices help avoid recalls, wasted product, and regulatory headaches. At every step, the basics still matter most: dry storage, strong labels, personal protection, and a readiness to react swiftly to any problem. These habits protect everyone, along with the final product.
Polyethylene Glycol 1500, commonly called PEG 1500, pops up on many pharmaceutical ingredient lists. As a solid at room temperature, PEG 1500 melts at body temperature and can work like a dream for both topical and internal medications. Those who have spent time on pharmaceutics assignments or anyone who has eased a headache with a melt-in-your-mouth tablet probably brushed past PEGs, sometimes without realizing their importance.
Combining PEG 1500 with other pharmaceutical materials doesn’t mean a pharmacist or manufacturer simply tosses powders together. Anyone who has filled capsules or worked with formulation labs knows the frustrations that can follow if materials lump, separate, or interact in odd ways.PEG 1500 suits many water-soluble compounds, such as sugars, lactose, and even certain starches. It can soften tablets, helping make solid oral doses that don’t crumble at the bottom of the bottle. Some common binders like microcrystalline cellulose or povidone blend without much trouble, but hydrophobic ingredients throw up red flags—they repel PEG 1500’s water-loving structure. If you have ever mixed oil and water in the kitchen, the challenge starts to make sense.Pharmaceutical journals highlight no major problems when PEG 1500 encounters most common fillers and binders. What you get comes down to the ratios and mixing conditions. For example, too much moisture can turn PEG-based blends sticky. Nobody wants an assembly line gummed up, so process control matters.
Active ingredients have their quirks. Some love water, some hate it, and many hover in the middle. PEG 1500 plays well with drugs that dissolve in water or those able to handle mild heat—think aspirin or acetaminophen. I remember years ago trying to prepare a quick-dissolve tablet that combined PEG 1500 with paracetamol; the compatibility meant smooth blending and reliable dose release.On the other hand, certain peptides, proteins, or moisture-sensitive actives may break down if exposed to the slightly hygroscopic nature of PEGs. Research shows that PEGs sometimes act as mild solvents, leading to slow degradation of unstable drugs over time. In practice, the shelf-life of complex products must be double-checked. Some antibiotics or vitamins, for instance, demand routine compatibility studies for every excipient combination.
No universal recipe works for every pill, cream, or suppository. Pharmacists and formulation scientists need to look up detailed compatibility data, run accelerated stability studies, and consult research for any signs of unwanted reactions—say, changes in texture, color, or breakdown products. Some resources, like the Handbook of Pharmaceutical Excipients and findings from the International Journal of Pharmaceutics, walk through dozens of examples and document possible incompatibilities.
Good practice always involves a close look at the intended route of delivery. For example, PEG 1500’s temperature sensitivity would not fit drugs stored in hot climates unless packaging keeps out extra heat. Some active molecules need antioxidants or buffering agents alongside PEGs, avoiding spoilage or loss of potency. For gels or ointments, checking for separation or changes after a few weeks can reveal slow, invisible issues.
Those in the lab or on production lines should keep an eye on guidance from regulatory agencies and recent case studies. Testing products under real-world temperature and humidity offers practical insights. Close work between formulation teams, testing labs, and quality assurance reduces missteps that might show up only months later on pharmacy shelves.PEG 1500 continues to serve as a versatile part of the pharmaceutical toolbox. Success means picking reliable supplier data, checking compatibility in real-time, and understanding the unique chemistry at play with every drug and excipient blend.
| Identifiers | |
| UN number | UN3082 |
| Pharmacology | |
| ATC code | A06AD15 |
Chengguan District, Lanzhou, Gansu, China
